What GE Ventures, Sanofi-Genzyme BioVentures and Nexus Venture Partners won’t invest in
At the annual Health 2.0 conference in Silicon Valley, a panel of venture capitalists describe areas of health tech that do not appeal to them.
Sanofi-Genzyme BioVentures